G. S. Nowakowski

685 total citations
9 papers, 429 citations indexed

About

G. S. Nowakowski is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, G. S. Nowakowski has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in G. S. Nowakowski's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). G. S. Nowakowski is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). G. S. Nowakowski collaborates with scholars based in United States, Sweden and Denmark. G. S. Nowakowski's co-authors include Eunhee S. Yi, Robert Vassallo, David J. Inwards, Patrick B. Johnston, Carrie A. Thompson, Thomas M. Habermann, Joseph P. Colgan, Luis F. Porrata, Ivana N. Micallef and T. E. Witzig and has published in prestigious journals such as Journal of Clinical Oncology, Leukemia and Haematologica.

In The Last Decade

G. S. Nowakowski

9 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. S. Nowakowski United States 6 203 160 100 91 89 9 429
Mónica García‐Cosío Spain 12 119 0.6× 199 1.2× 74 0.7× 66 0.7× 236 2.7× 37 554
Anjum Hassan United States 16 168 0.8× 220 1.4× 65 0.7× 28 0.3× 88 1.0× 39 540
Mariko Yabe United States 14 142 0.7× 199 1.2× 43 0.4× 87 1.0× 113 1.3× 39 466
Jake Allred United States 8 258 1.3× 83 0.5× 57 0.6× 62 0.7× 32 0.4× 13 373
Kong‐Chao Chang Taiwan 8 155 0.8× 111 0.7× 29 0.3× 73 0.8× 63 0.7× 10 319
Atsushi Notoya Japan 11 131 0.6× 170 1.1× 88 0.9× 35 0.4× 187 2.1× 28 484
Irene Ricca Italy 14 193 1.0× 221 1.4× 71 0.7× 93 1.0× 61 0.7× 28 504
Athina Androulaki Greece 12 148 0.7× 145 0.9× 45 0.5× 27 0.3× 31 0.3× 29 363
Barbara Vannata Italy 12 237 1.2× 347 2.2× 72 0.7× 20 0.2× 93 1.0× 23 584
Paola Rafaniello Raviele Italy 11 179 0.9× 137 0.9× 47 0.5× 56 0.6× 19 0.2× 25 406

Countries citing papers authored by G. S. Nowakowski

Since Specialization
Citations

This map shows the geographic impact of G. S. Nowakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. S. Nowakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. S. Nowakowski more than expected).

Fields of papers citing papers by G. S. Nowakowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. S. Nowakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. S. Nowakowski. The network helps show where G. S. Nowakowski may publish in the future.

Co-authorship network of co-authors of G. S. Nowakowski

This figure shows the co-authorship network connecting the top 25 collaborators of G. S. Nowakowski. A scholar is included among the top collaborators of G. S. Nowakowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. S. Nowakowski. G. S. Nowakowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Larson, Melissa C., Sara Ekberg, Karin E. Smedby, et al.. (2023). Multicohort Study of Conditional Survival and Cause of Death After Achieving Event‐Free Survival at 24 Months (EFS24) in Patients With Mantle Cell Lymphoma (MCL). Hematological Oncology. 41(S2). 472–474. 1 indexed citations
2.
Maurer, Matthew J., Thomas M. Habermann, G. S. Nowakowski, et al.. (2019). OUTCOMES AFTER EARLY TRANSFORMATION (tPOD24) VS. EARLY FOLLICULAR LYMPHOMA PROGRESSION (fPOD24) IN FOLLICULAR LYMPHOMA TREATED WITH FRONTLINE IMMUNOCHEMOTHERAPY. Hematological Oncology. 37(S2). 231–232. 3 indexed citations
3.
Tracy, Sean, Matthew J. Maurer, Thomas E. Witzig, et al.. (2017). Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma. Blood Cancer Journal. 7(8). e595–e595. 27 indexed citations
4.
Ding, Husheng, Kevin L. Peterson, Cristina Correia, et al.. (2016). Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells. Leukemia. 31(7). 1593–1602. 27 indexed citations
5.
Yi, Eunhee S., et al.. (2012). Pulmonary langerhans cell histiocytosis. Orphanet Journal of Rare Diseases. 7(1). 98 indexed citations
6.
Porrata, Luis F., Kay M. Ristow, Joseph P. Colgan, et al.. (2011). Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica. 97(2). 262–269. 162 indexed citations
7.
Buadi, Francis K., Angela Dispenzieri, Betsy LaPlant, et al.. (2011). Single-agent lenalidomide for newly diagnosed myeloma with on-demand dexamethasone: A phase II trial.. Journal of Clinical Oncology. 29(15_suppl). 8080–8080. 1 indexed citations
8.
Porrata, Luis F., David J. Inwards, Stephen M. Ansell, et al.. (2010). Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leukemia. 24(7). 1343–1349. 46 indexed citations
9.
Dooner, Gerri, et al.. (2001). The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells. Experimental Hematology. 29(11). 1326–1335. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mónica García‐Cosío Breakdown of academic impact, for papers by Anjum Hassan Breakdown of academic impact, for papers by Mariko Yabe Breakdown of academic impact, for papers by Jake Allred Breakdown of academic impact, for papers by Kong‐Chao Chang Breakdown of academic impact, for papers by Atsushi Notoya Breakdown of academic impact, for papers by Irene Ricca Breakdown of academic impact, for papers by Athina Androulaki Breakdown of academic impact, for papers by Barbara Vannata Breakdown of academic impact, for papers by Paola Rafaniello Raviele
Rankless by CCL
2026